Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry
Daniel M. Shindler, MD, FACC*,
Sebastian T. Palmeri, MD, FACC*,
Tracy A. Antonelli, MPH
,
Lynn A. Sleeper, ScD
,
Jean Boland, MD
,
Thomas P. Cocke, MD, FACC
,
Judith S. Hochman, MD, FACC|| for the SHOCK Investigators
* UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
New England Research Institutes, Watertown, Massachusetts, USA
Centre Hospitalier de la Citadelle, Liège, Belgium
Mt. Sinai Medical Center, New York, New York, USA
|| St. LukesRoosevelt Hospital, New York, New York, USA

View larger version (18K):
[in a new window]
|
Figure 1 Survival benefit in diabetics (black bars) and nondiabetics (white bars), overall and by selection for revascularization by angioplasty or bypass surgery. *Includes 36 patients who underwent both angioplasty and bypass surgery.
|
|
Copyright © 2000 by the American College of Cardiology Foundation.